{"article_id": "ABC_q1_2021.txt", "article": ["we delivered exceptional results driven by differentiated commercial solutions with revenues of $ 52.5 billion for the first fiscal quarter , representing growth of 10 % year - over - year and our adjusted earnings per share increasing 24 % versus the prior year quarter .", "one customer group , for whom we have consistently created new incremental value , is our independent pharmacy customers including our more than 5,000 good neighbor pharmacy and elevate provider network members .", "these include ensuring that mwi associates are accessible to our customers 24/7 and bolstering our customers ' abilities to offer virtual services to a pet caring clients including innovative client communication solutions and home delivery services of quality medications and pet care products .", "beginning with our first quarter results , we finished the quarter with adjusted diluted earnings per share of $ 2.18 , an increase of 24 % , primarily due to exceptional operating income growth across our businesses .", "our consolidated revenue was $ 52.5 billion , up 10 % , driven by revenue growth in both the pharmaceutical distribution services segment and other , which includes our global commercialization services & animal health businesses .", "gross profit increased 15 % to $ 1.4 billion , driven by increases in gross profit in each operating segment .", "in the quarter , gross profit margin increased 12 basis points from the prior year quarter .", "the pharmedium comparison and the inventory writedown reversal contributed one - third of the 12 basis point gross profit margin improvement .", "consolidated operating income was $ 617 million , up $ 122 million or 25 % compared to the prior year quarter .", "to support our revenue growth while protecting , supporting and appropriately compensating our frontline associates , operating expenses grew 8 % to $ 810 million .", "operating expenses as a percent of revenue was 1.54 % which is a 2 basis point decline from the prior year quarter .", "moving now to net interest expense , which increased $ 3 million to $ 34 million primarily due to a decrease in interest income resulting from a decline in investment interest rates .", "our effective tax rate was 22 % , up from 21 % , in the first quarter of fiscal 2020 .", "our diluted share count declined modestly to 206.8 million shares .", "regarding free cash flow and cash balance , our adjusted free cash flow was $ 838 million in the first quarter .", "we ended the quarter with $ 4.9 billion of cash of which $ 1.1 billion was held offshore .", "beginning with pharmaceutical distribution services , segment revenue was $ 50.5 billion , up 10 % , driven by increased specialty product sales , including covid - 19 therapies , as well as growth at some of our largest customers and broadly across our businesses .", "segment operating income increased about 27 % to $ 496 million with operating income margin up 13 basis points .", "as a reminder , the exit of the pharmedium business represented a $ 20 million tailwind to the segment 's operating income , roughly half of which is in gross profit and the other half in operating expense .", "excluding the pharmedium tailwind , segment operating income growth would have been up 20 % .", "in the quarter , total revenue was $ 2.1 billion , up 11 % , driven by growth across the three operating segments .", "operating income for the group was up $ 17 million or 16 % , primarily due to growth at mwi and world courier .", "given the cash needs associated with the alliance acquisition , we are narrowing our guidance from a range of 206 million to 207 million and we now expect to finish the year around 207 million shares outstanding ."], "summary_gold": "q1 adjusted non -gaap earnings per share $ 2.18 excluding items .<q>updating its outlook for fiscal year 2021 .<q>revenues of $ 52.5 billion for q1 , a 9.7 percent increase year - over - year .<q>sees fy 2021 revenue growth in high - single digit percent range , up from mid-single digit percent range .<q>all other previously communicated aspects of co's fiscal year 2021 financial guidance and assumptions remain same .", "summary_pred": "in the quarter , total revenue was $ 2.1 billion , up 11 % , driven by growth across the three operating segments .<q>excluding the pharmedium tailwind , segment operating income growth would have been up 20 % .<q>operating income for the group was up $ 17 million or 16 % , primarily due to growth at mwi and world courier .<q>regarding free cash flow and cash balance , our adjusted free cash flow was $ 838 million in the first quarter .<q>as a reminder , the exit of the pharmedium business represented a $ 20 million tailwind to the segment 's operating income , roughly half of which is in gross profit and the other half in operating expense .<q>to support our revenue growth while protecting , supporting and appropriately compensating our frontline associates , operating expenses grew 8 % to $ 810 million .<q>the pharmedium comparison and the inventory writedown reversal contributed one - third of the 12 basis point gross profit margin improvement .<q>our diluted share count declined modestly to 206.8 million shares .<q>these include ensuring that mwi associates are accessible to our customers 24/7 and bolstering our customers ' abilities to offer virtual services to a pet caring clients including innovative client communication solutions and home delivery services of quality medications and pet care products .<q>given the cash needs associated with the alliance acquisition , we are narrowing our guidance from a range of 206 million to 207 million and we now expect to finish the year around 207 million shares outstanding .<q>we delivered exceptional results driven by differentiated commercial solutions with revenues of $ 52.5 billion for the first fiscal quarter , representing growth of 10 % year - over - year and our adjusted earnings per share increasing 24 % versus the prior year quarter .<q>one customer group , for whom we have consistently created new incremental value , is our independent pharmacy customers including our more than 5,000 good neighbor pharmacy and elevate provider network members .<q>we ended the quarter with $ 4.9 billion of cash of which $ 1.1 billion was held offshore .", "len_article": 23, "len_summary_gold": 5, "len_summary_pred": 13, "len_sent_scores": 23}